Cooley Market Talks

In this edition of Cooley Market Talks, leaders from Cooley and Goldman Sachs share what they’re seeing across IPOs, M&A and capital strategy – and how companies are navigating decisions in the current market.

Thought leaders from the legal and financial industries touched on what’s driving renewed momentum behind tech initial public offerings (IPOs), how issuers are approaching timing and investor engagement, and what the next wave of listings could look like as we move into 2026.

Thought leaders unpacked the latest trends in activism and engagement, offering practical insights into how companies are responding, defending and preparing for what’s next.

Panelists explored the structural and strategic considerations for convertible notes offerings, one of the market’s hottest products. 

Panelists explored healthcare capital markets trends in 2025, offering key perspectives on market dynamics, strategic considerations for private and public companies, and growth opportunities.

Featuring an engaging fireside chat with the general counsel of Tempus AI, panelists delved into the details of the company’s $410.7 million initial public offering on the Nasdaq Global Select Market and subsequently announced $600 million agreement to acquire Ambry Genetics. 

Panelists discussed the state of capital and M&A markets, expected trends, the dual-track process, and exit considerations for healthcare and life sciences companies.

Thought leaders discussed the current landscape for capital markets and expected trends for 2024, with a particular focus on the healthcare and life sciences industry.